AI assistant
Sabre Insurance Group PLC Director's Dealing 2021
5341_dirs_2021-04-22_078b7140-ee8e-46aa-9567-8a7d773de6a3.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 3053W
Sabre Insurance Group PLC
22 April 2021
22 April 2021
Sabre Insurance Group plc ("Sabre" or the "Company")
Notification of transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
Sabre announces that on 21 April 2021, the following Directors and PDMRs of the Company were each granted an option under the Sabre 2017 Sharesave Plan (the "Plan") over ordinary shares of £0.001 in the Company as detailed below:
| Name | Position | No of shares subject to option | Option Price | Bonus Date |
| Geoff Carter | Chief Executive Officer | 4,680 | £1.923 | 1 July 2024 |
| Trevor Webb | Claims Director | 4,680 | £1.923 | 1 July 2024 |
| Adam Westwood | Chief Financial Officer | 9,360 | £1.923 | 1 July 2024 |
| Matt Wright | Chief Actuary | 4,680 | £1.923 | 1 July 2024 |
Subject to the terms of the Plan, the options will vest on the Bonus Date and be exercisable for a period of six months, subject to continued service with the Company.
This notification is made pursuant to Article 19 of the EU Market Abuse Regulation.
Additional Information:
Anneka Kingan - Company Secretary
PDMR transaction notification
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Geoff Carter
2
Reason for the notification
a)
Position/status
Chief Executive Officer
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Sabre Insurance Group Plc
b)
LEI
2138006RXRQ8P8VKGV98
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
A non-transferable option over ordinary shares in the Company under the Sabre 2017 Sharesave Plan ('the Option')
Identification code
GB00BYWVDP49
b)
Nature of the transaction
Grant of option
c)
Price(s) and volume(s)
| Price per share | Volume |
| £1.923 | 4,680 |
d)
Aggregated Information
Volume
Price
| Volume | Price per share |
| 4,680 | £1.923 |
e)
Date of transaction
21 April 2020
f)
Place of transaction
London Stock Exchange (XLON)
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Trevor Webb
2
Reason for the notification
a)
Position/status
Chief Actuary
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Sabre Insurance Group Plc
b)
LEI
2138006RXRQ8P8VKGV98
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
A non-transferable option over ordinary shares in the Company under the Sabre 2017 Sharesave Plan ('the Option')
Identification code
GB00BYWVDP49
b)
Nature of the transaction
Grant of option
c)
Price(s) and volume(s)
| Price per share | Volume |
| £1.923 | 4,680 |
d)
Aggregated Information
Volume
Price
| Volume | Price per share |
| 4,680 | £1.923 |
e)
Date of transaction
21 April 2020
f)
Place of transaction
London Stock Exchange (XLON)
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Adam Westwood
2
Reason for the notification
a)
Position/status
Chief Financial Officer
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Sabre Insurance Group Plc
b)
LEI
2138006RXRQ8P8VKGV98
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
A non-transferable option over ordinary shares in the Company under the Sabre 2017 Sharesave Plan ('the Option')
Identification code
GB00BYWVDP49
b)
Nature of the transaction
Grant of option
c)
Price(s) and volume(s)
| Price per share | Volume |
| £1.923 | 9,360 |
d)
Aggregated Information
Volume
Price
| Volume | Price per share |
| 9,360 | £1.923 |
e)
Date of transaction
21 April 2020
f)
Place of transaction
London Stock Exchange (XLON)
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Matt Wright
2
Reason for the notification
a)
Position/status
Chief Actuary
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Sabre Insurance Group Plc
b)
LEI
2138006RXRQ8P8VKGV98
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
A non-transferable option over ordinary shares in the Company under the Sabre 2017 Sharesave Plan ('the Option')
Identification code
GB00BYWVDP49
b)
Nature of the transaction
Grant of option
c)
Price(s) and volume(s)
| Price per share | Volume |
| £1.923 | 4,680 |
d)
Aggregated Information
Volume
Price
| Volume | Price per share |
| 4,680 | £1.923 |
e)
Date of transaction
21 April 2020
f)
Place of transaction
London Stock Exchange (XLON)
Additional Information:
Anneka Kingan - Company Secretary
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHVLLBLFZLZBBK